Skip to main content

GMOs in the Food Industry: Asset or Risk?

Are GMOs the Solution to Sustainable Food?

As the global population grows, the food industry faces the dual challenge of meeting rising demand for high-quality and safe food, while promoting a sustainable agri-food system. In this context, the role of genetically modified organisms (GMOs) is debated: are they an asset or a risk? 

Some view GMOs as potential solutions, while others voice concerns about their lasting impact on public health and on the environment. To address these concerns, the EU has set up a strict legal framework with an intricate market access authorization process for food & feed products. A more in-depth analysis on the regulatory framework and presence of GMOs in the food industry can be found here.

Due to recent scientific breakthroughs that lower the risks associated to genetic modifications, the regulator is proposing new legislation for the use and production of GMOs created through novel genomic techniques (NGT) in the food sector. The proposal, published on July 5th 2023, is aimed to open the European market to modified plants obtained through specific NGTs. It strives to support reaching EU climate goals, to enhance the Union's competitiveness in the agri-food sector and at the same time to still protect human & animal health and to preserve the environment.

Nonetheless, it remains to be seen if the proposed amendment of the regulation will succeed in its goal and governments will unquestionably need to invest in educational campaigns to change the public perception before reaching a wide adoption of GMO’s in the European diets. 

Key Contacts

Paulien Miltants

Senior Consultant, Risk Advisory

Paulien is a senior consultant in the TDRC team within the Risk Advisory department of Deloitte Belgium and is a member of the Quality & Compliance sub radar. She completed a Master in Bioscience Engineering in which I majored in Food Technology - Food and Health and did a minor in Bio-economics and -policy. Her scientific background as bioscience engineer provides a critical mindset to serve companies to achieve their goals & objectives. Since starting at Deloitte, Paulien has been involved in Computer System Validation, Quality Assurance and Regulatory compliance engagements, building up experience and knowledge in these areas. 

Michel De Ridder

Partner, Risk Advisory

Michel is a partner in our Risk Advisory department with a main focus on the Life Sciences & Healthcare industry and on government. Within Deloitte Michel is the European competence leader for regulatory compliance services for IT. With more than 15 years of experience in the Life Sciences industry, Michel advised several companies in strategic risk management, project quality assurance, internal controls, regulatory compliance, quality management systems and system validation. Within his career, Michel had the chance to work in different areas from R&D to commercial as well as in supporting functions such as IT, quality and finance.